The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis

References

• Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Podgórski M, Jurowski P. The role of angiogenesis factors in the formation of vascular changes in scleroderma by assessment of the concentrations of VEGF and sVEGFR2 in blood serum and tear fluid. Mediators Inflamm. 2020;2020:7649480. doi:10.1155/2020/7649480
   PubMed Web of Science ®Google Scholar
• Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol. 2015;37(5):489–500. doi:10.1007/s00281-015-0505-5
   PubMed Web of Science ®Google Scholar
• Ruaro B, Smith V, Sulli A, et al. Innovations in the assessment of primary and secondary Raynaud’s phenomenon. Front Pharmacol. 2019;10:360. doi:10.3389/fphar.2019.00360
   PubMed Web of Science ®Google Scholar
• Rosendahl AH, Schönborn K, Krieg T. Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung J Med Sci. 2022;38(3):187–195. doi:10.1002/kjm2.12505
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Sato S, Ihn H, Takehara K. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Rheumatology. 1999;38(7):612–617. doi:10.1093/rheumatology/38.7.612
   PubMed Web of Science ®Google Scholar
• Branisteanu DE, Pirvulescu RA, Spinu AE, et al. Metabolic comorbidities of psoriasis (Review). Exp Ther Med. 2022;23(2):179. doi:10.3892/etm.2021.11102
   PubMed Web of Science ®Google Scholar
• Toledo DM, Pioli PA. Macrophages in systemic sclerosis: novel insights and therapeutic implications. Curr Rheumatol Rep. 2019;21(7):31. doi:10.1007/s11926-019-0831-z
   PubMed Web of Science ®Google Scholar
• Cristodor PL, Nechifor A, Fotea S, et al. New antifibroblastic medication in dermatology: could nintedanib treat scarring? Int J Gen Med. 2022;15:7169–7172. doi:10.2147/IJGM.S377073
   PubMed Web of Science ®Google Scholar
• Roumm AD, Whiteside TL, Medsger TA, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum. 1984;27(6):645–653. doi:10.1002/art.1780270607
   PubMedGoogle Scholar
• Niculet E, Chioncel V, Elisei AM, et al. Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review). Exp Ther Med. 2021;21(3):263. doi:10.3892/etm.2021.9693
   PubMed Web of Science ®Google Scholar
• Tatu AL, Nadasdy T, Arbune A, et al. Interrelationship and sequencing of interleukins 4, 13, 31 and 33 – an integrated systematic review: dermatological and multidisciplinary perspectives. J Inflamma Res. 2022;15:5163–5184. doi:10.2147/JIR.S374060
   PubMed Web of Science ®Google Scholar
• Bobeica C, Niculet E, Craescu M, et al. Hearing loss secondary to systemic sclerosis vasculopathy: case study with a short review. Clin Cosmet Invest Dermatol. 2022;15:967–973. doi:10.2147/CCID.S356818
   PubMed Web of Science ®Google Scholar
• Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med. 1989;170(3):727–737. doi:10.1084/jem.170.3.727
   PubMed Web of Science ®Google Scholar
• Vasile CI, Vasile MC, Zlati ML, et al. Post COVID-19 Infection Psychosis: could SARS-CoV-2 Virus Infection Be a Neuropsychiatric Condition That Triggers Psychotic Disorders? - A Case-Based Short Review. Infect Drug Resist. 2022;15:4697–4705. doi:10.2147/IDR.S373578
   PubMed Web of Science ®Google Scholar
• Tatu AL, Nwabudike LC. Male genital lichen sclerosus — a permanent therapeutic challenge. J Am Acad Dermatol. 2018;79(3Suppl1):AB185. doi:10.1016/j.jaad.2018.05.750
   Google Scholar
• Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol. 1997;24(2):328–332.
   PubMed Web of Science ®Google Scholar
• Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 1994;15(1):19–26. doi:10.1016/0167-5699(94)90021-3
   PubMedGoogle Scholar
• Doucet C, Brouty-Boyé D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecules and inflammatory cytokine expression in human lung fibroblasts. Int Immunol. 1998;10(10):1421–1433. doi:10.1093/intimm/10.10.1421
   PubMed Web of Science ®Google Scholar
• Bobeica C, Niculet E, Halip AI, et al. Predictive value of immunological markers in systemic sclerosis. Exp Ther Med. 2021;22(3):994. doi:10.3892/etm.2021.10426
   PubMed Web of Science ®Google Scholar
• Tatu AL, Nwabudike LC. Bullous reactions associated with COX-2 inhibitors. Am J Ther. 2017;24(4):e477–e480. doi:10.1097/MJT.0000000000000569
   PubMed Web of Science ®Google Scholar
• Sharad J. Hyaluronic acid filler injection for localized scleroderma - Case report and review of literature on filler injections for localized scleroderma. Clin Cosmet Invest Dermatol. 2022;15:1627–1637. doi:10.2147/CCID.S356641
   PubMed Web of Science ®Google Scholar
• Osuna-Gómez R, Castellví I, Mulet M, Ortiz MÀ. Impaired regulation by IL-35 in systemic sclerosis. Int J Mol Sci. 2023;24(13):10567. doi:10.3390/ijms241310567
   PubMed Web of Science ®Google Scholar
• Massagué J. TGFβ signaling in context. Nat Rev Mol Cell Biol. 2012;13(10):616–630. doi:10.1038/nrm3434
   PubMed Web of Science ®Google Scholar
• Higashi-Kuwata N, Jinnin M, Makino T, et al. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther. 2010;12(4):R128. doi:10.1186/ar3066
   PubMed Web of Science ®Google Scholar
• Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: the old and the new. Clin Cosmet Invest Dermatol. 2020;13:1041–1050. doi:10.2147/CCID.S224211
   PubMed Web of Science ®Google Scholar
• Sahin H, Wasmuth HE. Chemokines in tissue fibrosis. Biochim Biophys Acta. 2013;1832(7):1041–1048. doi:10.1016/j.bbadis.2012.11.004
   PubMed Web of Science ®Google Scholar
• Smith G, McLeod D, Foreman D, Boulton M. Immunolocalization of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. Br J Ophthalmol. 1999;83(4):486–494. doi:10.1136/bjo.83.4.486
   PubMed Web of Science ®Google Scholar
• Choi JJ, Min DJ, Cho ML, et al. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol. 2003;30(7):1529–1533.
   PubMed Web of Science ®Google Scholar
• Ozcelik O, Haytac MC, Ergin M, Antmen B, Seydaoglu G. The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation. Oral Surg, Oral Med Oral Pathol Oral Radiol Endod. 2008;105(4):481–485. doi:10.1016/j.tripleo.2007.07.021
   PubMed Web of Science ®Google Scholar
• Distler O, Del Rosso A, Giacomelli R, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4(6):R11. doi:10.1186/ar596
   PubMedGoogle Scholar
• Waszczykowska A, Goś R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P. Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients. Postepy Dermatol Allergol. 2014;31(1):6–11. doi:10.5114/pdia.2014.40653
   PubMed Web of Science ®Google Scholar
• Tatu AL, Ionescu MA, Cristea VC. Demodex folliculorum associated Bacillus pumilus in lesional areas in rosacea. Indian J Dermatol Venereol Leprol. 2017;83(5):610–611. doi:10.4103/ijdvl.IJDVL_921_16
   PubMed Web of Science ®Google Scholar
• Suliman YA, Distler O. Novel aspects in the pathophysiology of peripheral vasculopathy in systemic sclerosis. Curr Rheumatol Rev. 2013;9(4):237–244. doi:10.2174/157339710904140417123932
   PubMedGoogle Scholar
• Nwabudike LC, Tatu AL. Magistral prescription with silver nitrate and Peru Balsam in difficult-to-heal diabetic foot ulcers. Am J Ther. 2018;25(6):e679–e680. doi:10.1097/MJT.0000000000000622
   PubMed Web of Science ®Google Scholar
• Johnson SR, van den Hoogen F, Devakandan K, Matucci-Cerinic M, Pope JE. Systemic sclerosis: to subset or not to subset, that is the question. Eur J Rheumatol. 2020;7(Suppl 3):S222–S227. doi:10.5152/eurjrheum.2020.19116
   PubMed Web of Science ®Google Scholar
• Bobeica C, Niculet E, Craescu M, et al. CREST syndrome in systemic sclerosis patients - is dystrophic calcinosis a key element to a positive diagnosis? J Inflam Res. 2022;15:3387–3394. doi:10.2147/JIR.S361667
   PubMed Web of Science ®Google Scholar
• Adigun R, Goyal A, Hariz A. Systemic Sclerosis. Treasure Island (FL): SteatPearls Publishing; 2023.
   Google Scholar
• Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65(8):1953–1962. doi:10.1002/art.37988
   PubMed Web of Science ®Google Scholar
• Lupu MN, Miulescu M, Stefanopol IA, et al. Effect of 2,6-diisopropylphenol and 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy) propane as Anesthetic. Rev.Chim. 2019;70(5):1888–1892.
   Web of Science ®Google Scholar
• Masi AT, Medsger TA Jr. Progress in the evolution of systemic sclerosis classification criteria and recommendation for additional comparative specificity studies. J Rheumatol. 2015;42(1):8–10. doi:10.3899/jrheum.141020
   PubMed Web of Science ®Google Scholar
• Tyndal AJ, Bannert B, Vonk M, et al. Causes and risk factors of death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809–1815. doi:10.1136/ard.2009.114264
   PubMed Web of Science ®Google Scholar
• Haustein UF. Systemic sclerosis-scleroderma. Dermatol Online J. 2002;8(1):3.
   PubMedGoogle Scholar
• LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
   PubMed Web of Science ®Google Scholar
• Giuggioli D, Magnani L, Spinella A, et al. Infections of scleroderma digital ulcers: a single center cohort retrospective study. Dermatol Reports. 2021;13(3):9075. doi:10.4081/dr.2021.9075
   PubMedGoogle Scholar